CSIMarket
 


Akers Biosciences Inc   (AKER)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Akers Biosciences Inc 's Tangible Leverage Ratio

AKER's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth




AKER Tangible Leverage Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Tangible Equity Change 40.7 % 64.3 % -49.61 % -58.04 % -54.18 %
Y / Y Total Liabilities Change 10.98 % -22.48 % -40.34 % -12.65 % 50.52 %
Tangible Leverage Ratio MRQ 0.35 0.17 0.41 0.4 0.44
Overall Ranking # # # # #
Seq. Tangible Equity Change -27.5 % 171.35 % -17.26 % -13.56 % -15.34 %
Seq. Total Liabilities Change 50.63 % 11.42 % -15.13 % -22.09 % 5.22 %



Tangible Leverage Ratio first quarter 2020 Comment
Due to net new borrowings of 50.63%, Tangible Leverage Ratio detoriated to 0.35, above company's average Tangible Leverage Ratio.

Within Biotechnology & Drugs industry in the first quarter 2020, 75 other companies have achieved lower Tangible Leverage Ratio than Akers Biosciences Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Tangible Leverage Ratio?
What is AKER Market Share?
Tangible Leverage Ratio first quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 76
Healthcare Sector # 226
Overall Market # 510


Tangible Leverage Ratio Statistics
High Average Low
0.5 0.25 0.07
(Dec 31 2016)   (Jun 30 2014)




Financial Statements
Akers Biosciences Inc 's Tangible Equity $ 7 Millions Visit AKER's Balance sheet
Akers Biosciences Inc 's Total Liabilities $ 2 Millions Visit AKER's Balance sheet
Source of AKER's Sales Visit AKER's Sales by Geography




Companies with similar Tangible Leverage Ratio in the quarter endingMar 31 2020, within Biotechnology & Drugs Industry Tangible Leverage RatioMar 31 2020 MRQ Total LiabilitiesMar 31 2020 MRQ Tangible Equity
Neurocrine Biosciences Inc   0.94 $ 661.600  Millions$ 700.300  Millions
Sun Biopharma Inc   0.93 $ 0.670  Millions$ 0.724  Millions
Vitality Biopharma Inc   0.90 $ 1.159  Millions$ 1.282  Millions
Volitionrx Ltd  0.87 $ 7.680  Millions$ 8.849  Millions
Celldex Therapeutics Inc   0.82 $ 28.801  Millions$ 35.013  Millions
Eloxx Pharmaceuticals Inc   0.79 $ 20.784  Millions$ 26.257  Millions
Cyanotech Corp  0.78 $ 12.422  Millions$ 15.846  Millions
Repligen Corp  0.78 $ 305.938  Millions$ 392.850  Millions
Evelo Biosciences Inc   0.78 $ 30.546  Millions$ 39.344  Millions
Aclaris Therapeutics Inc   0.75 $ 38.088  Millions$ 50.995  Millions
Obalon Therapeutics Inc  0.74 $ 8.157  Millions$ 11.072  Millions
Voyager Therapeutics Inc   0.71 $ 56.703  Millions$ 79.757  Millions
Strongbridge Biopharma plc  0.71 $ 21.368  Millions$ 30.068  Millions
Oncternal Therapeutics Inc   0.70 $ 7.269  Millions$ 10.395  Millions
Pulse biosciences inc   0.69 $ 10.073  Millions$ 14.596  Millions
Trovagene Inc   0.68 $ 4.152  Millions$ 6.143  Millions
Aptevo Therapeutics Inc   0.67 $ 10.092  Millions$ 15.152  Millions
Axcella Health Inc   0.66 $ 30.768  Millions$ 46.814  Millions
Xenetic Biosciences Inc   0.64 $ 4.426  Millions$ 6.956  Millions
Sangamo Therapeutics Inc   0.63 $ 189.985  Millions$ 303.728  Millions
Cidara Therapeutics Inc   0.56 $ 30.345  Millions$ 53.752  Millions
Adaptimmune Therapeutics Plc  0.54 $ 99.204  Millions$ 183.671  Millions
Armata Pharmaceuticals Inc   0.54 $ 10.620  Millions$ 19.736  Millions
Axovant Gene Therapies Ltd.  0.52 $ 32.122  Millions$ 61.558  Millions
Unum Therapeutics Inc   0.52 $ 13.237  Millions$ 25.702  Millions
Pluristem Therapeutics Inc  0.50 $ 7.068  Millions$ 14.169  Millions
Unity Biotechnology Inc   0.50 $ 52.458  Millions$ 105.329  Millions
Capricor Therapeutics Inc   0.49 $ 4.673  Millions$ 9.587  Millions
Fate Therapeutics Inc  0.47 $ 102.672  Millions$ 219.218  Millions
Orgenesis Inc   0.46 $ 37.695  Millions$ 81.997  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WNEB's Profile

Stock Price

WNEB's Financials

Business Description

Fundamentals

Charts & Quotes

WNEB's News

Suppliers

WNEB's Competitors

Customers & Markets

Economic Indicators

WNEB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071